Sirt1: A guardian of the development of diabetic retinopathy

Diabetes

Volumn 67, Issue 4, 2018, Pages 745-754

  Mishra, Manish ^a   Duraisamy, Arul J ^a   Kowluru, Renu A ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; GLUCOSE; SIRTUIN 1; MESSENGER RNA; SIRT1 PROTEIN, MOUSE; TRANSCRIPTOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CAPILLARY; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA METHYLATION; DOWN REGULATION; ELECTRORETINOGRAPHY; EPIGENETICS; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; MALE; MICROVASCULATURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RETINA; RETINAL GANGLION CELL LAYER; VASCULARIZATION; ANIMAL; BLOOD RETINA BARRIER; CAPILLARY PERMEABILITY; COMPLICATION; EXPERIMENTAL DIABETES MELLITUS; GENETIC EPIGENESIS; GENETICS; METABOLISM; ORGAN SIZE; PATHOLOGY; RETINA BLOOD VESSEL;

ANIMALS; APOPTOSIS; BLOOD-RETINAL BARRIER; CAPILLARY PERMEABILITY; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; DNA METHYLATION; ELECTRORETINOGRAPHY; EPIGENESIS, GENETIC; MICE; MICROVESSELS; ORGAN SIZE; PROMOTER REGIONS, GENETIC; RETINA; RETINAL VESSELS; RNA, MESSENGER; SIRTUIN 1; TRANSCRIPTOME;

EID: 85044482709     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db17-0996     Document Type: Article

References (50)

1. Frank RN. Diabetic retinopathy. N Engl J Med 2004;350:48-58
2. Kowluru RA, Kowluru A, Mishra M, Kumar B. Oxidative stress and epigenetic modifications in the pathogenesis of diabetic retinopathy. Prog Retin Eye Res 2015; 48:40-61
3. Kowluru RA. Diabetic retinopathy, metabolic memory and epigenetic modifications. Vision Res 2017;139:30-38
4. Mizutani M, Kern TS, Lorenzi M. Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. J Clin Invest 1996;97:2883-2890
5. Kern TS, Barber AJ. Retinal ganglion cells in diabetes. J Physiol 2008;586: 4401-4408
6. Brooks CL, Gu W. How does SIRT1 affect metabolism, senescence and cancer Nat Rev Cancer 2009;9:123-128
7. Li X. SIRT1 and energy metabolism. Acta Biochim Biophys Sin (Shanghai) 2013;45:51-60
8. Hwang JW, Yao H, Caito S, Sundar IK, Rahman I. Redox regulation of SIRT1 in inflammation and cellular senescence. Free Radic Biol Med 2013;61:95-110
9. Tanno M, Sakamoto J, Miura T, Shimamoto K, Horio Y. Nucleocytoplasmic shuttling of the NAD+-dependent histone deacetylase SIRT1. J Biol Chem 2007;282: 6823-6832
10. Mimura T, Kaji Y, Noma H, Funatsu H, Okamoto S. The role of SIRT1 in ocular aging. Exp Eye Res 2013;116:17-26
11. Kowluru RA, Santos JM, Zhong Q. Sirt1, a negative regulator of matrix metalloproteinase-9 in diabetic retinopathy. Invest Ophthalmol Vis Sci 2014;55: 5653-5660
12. Pavlová S, Klucska K, Vaší-cek D, et al. The involvement of SIRT1 and transcription factor NF-kB (p50/p65) in regulation of porcine ovarian cell function. Anim Reprod Sci 2013;140:180-188
13. Kowluru RA, Mohammad G, dos Santos JM, Zhong Q. Abrogation of MMP-9 gene protects against the development of retinopathy in diabetic mice by preventing mitochondrial damage. Diabetes 2011;60:3023-3033
14. Mishra M, Flaga J, Kowluru RA. Molecular mechanism of transcriptional regulation of matrix metalloproteinase-9 in diabetic retinopathy. J Cell Physiol 2016;231: 1709-1718
15. Caito S, Rajendrasozhan S, Cook S, et al. SIRT1 is a redox-sensitive deacetylase that is post-translationally modified by oxidants and carbonyl stress. FASEB J 2010;24:3145-3159
16. Chung S, Yao H, Caito S, Hwang JW, Arunachalam G, Rahman I. Regulation of SIRT1 in cellular functions: Role of polyphenols. Arch Biochem Biophys 2010;501: 79-90
17. Reddy MA, Zhang E, Natarajan R. Epigenetic mechanisms in diabetic complications and metabolic memory. Diabetologia 2015;58:443-455
18. Regha K, Sloane MA, Huang R, et al. Active and repressive chromatin are interspersed without spreading in an imprinted gene cluster in the mammalian genome. Mol Cell 2007;27:353-366
19. Kowluru RA, Shan Y, Mishra M. Dynamic DNA methylation of matrix metalloproteinase-9 in the development of diabetic retinopathy. Lab Invest 2016;96: 1040-1049
20. Mishra M, Kowluru RA. Epigenetic modification of mitochondrial DNA in the development of diabetic retinopathy. Invest Ophthalmol Vis Sci 2015;56:5133-5142
21. Zhong Q, Kowluru RA. Regulation of matrix metalloproteinase-9 by epigenetic modifications and the development of diabetic retinopathy. Diabetes 2013; 62:2559-2568
22. Mishra M, Kowluru RA. Role of PARP-1 as a novel transcriptional regulator of MMP-9 in diabetic retinopathy. Biochim Biophys Acta 2017;1863:1761-1769
23. Kowluru RA, Mishra M, Kowluru A, Kumar B. Hyperlipidemia and the development of diabetic retinopathy: Comparison between type 1 and type 2 animal models. Metabolism 2016;65:1570-1581
24. Mohammad G, Kowluru RA. Matrix metalloproteinase-2 in the development of diabetic retinopathy and mitochondrial dysfunction. Lab Invest 2010;90:1365-1372
25. Liu CH, Sun Y, Li J, et al. Endothelial microRNA-150 is an intrinsic suppressor of pathologic ocular neovascularization. Proc Natl Acad Sci USA 2015;112:12163-12168
26. Gao G, Shao C, Zhang SX, Dudley A, Fant J, Ma JX. Kallikrein-binding protein inhibits retinal neovascularization and decreases vascular leakage. Diabetologia 2003;46:689-698
27. Zudaire E, Gambardella L, Kurcz C, Vermeren S. A computational tool for quantitative analysis of vascular networks. PLoS One 2011;6:e27385
28. Hasegawa E, Sweigard H, Husain D, et al. Characterization of a spontaneous retinal neovascular mouse model. PLoS One 2014;9:e106507
29. Mishra M, Kowluru RA. Retinal mitochondrial DNA mismatch repair in the development of diabetic retinopathy, and its continued progression after termination of hyperglycemia. Invest Ophthalmol Vis Sci 2014;55:6960-6967
30. Sun Y, Ju M, Lin Z, et al. SOCS3 in retinal neurons and glial cells suppresses VEGF signaling to prevent pathological neovascular growth. Sci Signal 2015;8:ra94
31. Tan J, Liu Y, Li W, Gao Q. Ocular pathogenesis and immune reaction after intravitreal dispase injection in mice. Mol Vis 2012;18:887-900
32. Tang BL. Sirt1 and the Mitochondria. Mol Cells 2016;39:87-95
33. Santos JM, Tewari S, Goldberg AFX, Kowluru RA. Mitochondrial biogenesis and the development of diabetic retinopathy. Free Radic Biol Med 2011;51:1849-1860
34. Deaton AM, Bird A. CpG islands and the regulation of transcription. Genes Dev 2011;25:1010-1022
35. Peng L, Yuan Z, Ling H, et al. SIRT1 deacetylates the DNA methyltransferase 1 (DNMT1) protein and alters its activities. Mol Cell Biol 2011;31: 4720-4734
36. van Dijk HW, Verbraak FD, Kok PH, et al. Early neurodegeneration in the retina of type 2 diabetic patients. Invest Ophthalmol Vis Sci 2012;53:2715-2719
37. Jko H, Wencel P, Strosznajder RP, Strosznajder JB. Sirtuins and their roles in brain aging and neurodegenerative disorders. Neurochem Res 2017;42:876-890
38. Chong ZZ, Wang S, Shang YC, Maiese K. Targeting cardiovascular disease with novel SIRT1 pathways. Future Cardiol 2012;8:89-100
39. Banks AS, Kon N, Knight C, et al. SirT1 gain of function increases energy efficiency and prevents diabetes in mice. Cell Metab 2008;8:333-341
40. Herranz D, Serrano M. SIRT1: Recent lessons from mouse models. Nat Rev Cancer 2010;10:819-823
41. Kern TS, Tang J, Mizutani M, et al. Response of capillary cell death to aminoguanidine predicts the development of retinopathy: Comparison of diabetes and galactosemia. Invest Ophthalmol Vis Sci 2000;41:3972-3978
42. Liu S, Lin YU, Liu X. Protective effects of SIRT1 in patients with proliferative diabetic retinopathy via the inhibition of IL-17 expression. Exp Ther Med 2016;11: 257-262
43. Hammer SS, Beli E, Kady N, et al. The mechanism of diabetic retinopathy pathogenesis unifying key lipid regulators, Sirtuin 1 and liver X receptor. EBioMedicine 2017;22:181-190
44. Zeng Y, Yang K. Sirtuin 1 participates in the process of age-related retinal degeneration. Biochem Biophys Res Commun 2015;468:167-172
45. Kim AY, Chu Z, Shahidzadeh A, Wang RK, Puliafito CA, Kashani AH. Quantifying microvascular density and morphology in diabetic retinopathy using spectral-domain optical coherence tomography angiography. Invest Ophthalmol Vis Sci 2016;57: OCT362-OCT370
46. Wang S, Wang J, Zhao A, Li J. SIRT1 activation inhibits hyperglycemia-induced apoptosis by reducing oxidative stress and mitochondrial dysfunction in human endothelial cells. Mol Med Rep 2017;16:3331-3338
47. Guarente L. Linking DNA damage, NAD(+)/SIRT1, and aging. Cell Metab 2014; 20:706-707
48. Crowe DL, Brown TN. Transcriptional inhibition of matrix metalloproteinase 9 (MMP-9) activity by a c-fos/estrogen receptor fusion protein is mediated by the proximal AP-1 site of the MMP-9 promoter and correlates with reduced tumor cell invasion. Neoplasia 1999;1:368-372
49. Yacoub R, Lee K, He JC. The role of SIRT1 in diabetic kidney disease. Front Endocrinol (Lausanne) 2014;5:166
50. Hou Y, Chen H, He Q, et al. Changes in methylation patterns of multiple genes from peripheral blood leucocytes of Alzheimer's disease patients. Acta Neuropsychiatr 2013;25:66-76